A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma
Yanxia He,Zhumei Luo,Haoqing Chen,Liqing Ping,Cheng Huang,Yan Gao,Huiqiang Huang
DOI: https://doi.org/10.2147/jir.s452521
IF: 4.5
2024-04-05
Journal of Inflammation Research
Abstract:Yanxia He, 1, &ast Zhumei Luo, 1, &ast Haoqing Chen, 2, 3, &ast Liqing Ping, 2, 3 Cheng Huang, 2, 3 Yan Gao, 2, 3 Huiqiang Huang 2, 3 1 Department of Oncology, The Third People's Hospital of Chengdu, Sichuan, People's Republic of China; 2 State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China; 3 Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Huiqiang Huang; Yan Gao, Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China, Email ; Background: Systemic inflammation, immunity, and nutritional status are closely related to patients' outcomes in several kinds of cancers. This study aimed to establish a new nomogram based on inflammation-immunity-nutrition score (IINS) to predict the prognosis of extranodal natural killer/T-cell lymphoma (ENKTL) patients. Methods: The clinical data of 435 patients with ENTKL were retrospectively reviewed and randomly assigned to training cohort (n=305) and validation cohort (n=131) at a ratio of 7:3. Cox regression analysis was employed to identify independent prognostic factors and develop a nomogram in the training cohort. Harrell's concordance index (C-index), calibration curve, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA) curve were employed to assess the performance of the nomogram and compare it with traditional prognostic systems (PINK, IPI, KPI). Internal validation was performed using 1000 bootstrap resamples in the validation cohort. Kaplan-Meier survival analyses were conducted to compare the overall survival (OS) of patients in different risk groups. Results: In the training cohort, in addition to several classic parameters, IINS was identified as an independent prognostic factor significantly associated with the OS of patients. The nomogram established based on the independent prognostic indicators showed superior survival prediction efficacy, with C-index of 0.733 in the training cohort and 0.759 in the validation cohort compared to the PINK (0.636 and 0.737), IPI (0.81 and 0.707), and KPI (0.693 and 0.639) systems. Furthermore, compared with PINK, IPI, and IPI systems, the nomogram showed relatively superior calibration curves and more powerful prognostic discrimination ability in predicting the OS of patients. DCA curves revealed some advantages in terms of clinical applicability of the nomogram compared to the PINK, IPI, and IPI systems. Conclusion: Compared with traditional prognostic systems, the nomogram showed promising prospects for risk stratification in ENKTL patient prognosis, providing new insights into the personalized treatment. Keywords: inflammation-immunity-nutrition score, extranodal natural killer/T-cell lymphoma, nomogram, prognosis, overall survival Extranodal natural killer/T-cell lymphoma (ENKTL), characterized by malignant proliferation of natural killer cells and cytotoxic T lymphocytes, is a distinctly heterogeneous clinicopathological entity primarily occurring in Asia and South America. 1,2 In recent years, with the optimization of radiotherapy and L-asparaginase-based chemotherapy regimens, the survival rate of ENKTL patients has markedly improved. However, approximately 50% of patients with advanced-stage ENKTL usually develop relapsed/refractory (r/r) disease, and the outcomes in these populations remain dismal. 3,4 Several prognostic systems, such as the Prognostic Index for Natural Killer Lymphoma (PINK), International Prognostic Index (IPI), and Korean prognostic index (KPI), are widely used in ENKTL to stratify risk and predict the outcomes of patients, while these models do not produce accurate risk stratification to some extent. 5–8 In addition, both the IPI and KPI prognostic systems were proposed for patients who were treated with anthracycline-containing regimens, such as CHOP and CHOP-like, and may not be fully applicable in the era of nonanthracycline chemotherapy. 5,8 Therefore, it is extremely important to explore a more efficient and accurate prognosis evaluation system for ENKTL. In recent years, growing evidence has indicated that the inflammatory response, immunity and nutrition status of individuals have a close relationship with the occurrence, progression, and metastasis of tumours. 9,10 Many studies have reported that the ratios of different perip -Abstract Truncated-
immunology